Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2015-08-21

Clinical Trial Update: Mivacurium Chloramine Muscle Relaxation Effect in Patients With Liver Cirrhosis [Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 2 study of mivacurium chloramine for muscle relaxation effects in patients with liver cirrhosis; the trial status i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mivacurium Chloramine (mivacurium)

Snippet

Sponsor: Tang-Du Hospital | Conditions: Liver Dysfunction | Phase 2 | Status: UNKNOWN